SZELA MARY T (CEO and President) purchased 4.0% of their position (14.81K shares) of TRISALUS LIFE SCIENCES, INC. on the open market
Open‑market purchase worth $75.4K — a small addition. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 9/13/2024ACC: 0001415889-24-023390
DirectorOfficer· CEO and President
Since Feb 2026
+14.81K
Net shares
Net buyer
$75.4K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
14.81K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+7.52K
Price / share
$5.20
Trade value
$39.10K
% of position
2.0%
9/12/2024
369.86K→377.38K
Common Stock
Direct
Shares
+1.29K
Price / share
$4.83
Trade value
$6.25K
% of position
0.3%
9/13/2024
377.38K→378.68K
Common Stock
Direct
Shares
+6K
Price / share
$5.00
Trade value
$30K
% of position
1.6%
9/13/2024
378.68K→384.68K
Total
Net shares
+14.81K
Net value
$75.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/12/2024 | P · Purchase | +7.52K | $5.20 | $39.10K | 2.0% | 369.86K | 377.38K |
| Common Stock Direct | 9/13/2024 | P · Purchase | +1.29K | $4.83 | $6.25K | 0.3% | 377.38K | 378.68K |
| Common Stock Direct | 9/13/2024 | P · Purchase | +6K | $5.00 | $30K | 1.6% | 378.68K | 384.68K |
| Total | +14.81K | $75.36K | ||||||
Derivative Transactions0
No derivative transactions reported